Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Date of Report (Date of earliest event reported) May 10, 2004
ENDOLOGIX, INC.
DELAWARE | 0-28440 | 68-0328265 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
13900 ALTON PARKWAY, SUITE 122 IRVINE, CA | 92618 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (949) 595-7200
Item 7. Financial Statements and Exhibits. | ||||||||
Item 9. Regulation FD Disclosure. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Table of Contents
Item 7. Financial Statements and Exhibits.
99.1 | Press Release, dated May 10, 2004, issued by Endologix, Inc. |
Item 9. Regulation FD Disclosure.
The information included in this section is intended to be included under “Item 12. Disclosure of Results of Operations and Financial Condition” and is included under this Item 9 in accordance with SEC Release No. 33-8216.
On May 10, 2004, Endologix, Inc. announced financial results for the first quarter ended March 31, 2004. A copy of the press release making this announcement is attached hereto as Exhibit 99.1 and incorporated herein by reference. The press release shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ENDOLOGIX, INC. | ||||
Date: May 12, 2004 | By: | /s/ David Richards | ||
Chief Financial Officer | ||||
and Secretary |
3